'PE Firms Eye €7.5 Billion Leveraged Financing For Sanofi Unit; Consumer-Health Unit Could Be One Of Biggest Recent LBOs; CD&R Among Private Equity Firms Looking At Consumer Unit' - Bloomberg News
Portfolio Pulse from Benzinga Newsdesk
Private equity firms, including CD&R, are considering leveraged financing of approximately €7.5 billion ($8.16 billion) for the acquisition of Sanofi's consumer health division. This potential deal could rank as one of the largest leveraged buyouts in recent history. The financing is expected to involve both banks and direct lenders.
March 15, 2024 | 4:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sanofi's consumer health division is the target of a potential €7.5 billion leveraged buyout by private equity firms, including CD&R.
The news of a potential leveraged buyout of Sanofi's consumer health division by prominent private equity firms, involving a significant amount of financing, indicates a positive outlook for Sanofi. This could lead to an increase in investor confidence in SNY, potentially driving up its stock price in the short term. The size of the deal underscores the value and attractiveness of Sanofi's consumer health division, further bolstering the positive impact on SNY's stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90